GlucoTrack, Inc.
GCTK
$0.1714
-$0.0026-1.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 219.26% | 123.73% | 63.41% | 25.08% | 0.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.45% | 46.18% | 280.92% | 129.83% | 87.80% |
| Operating Income | -59.45% | -46.18% | -280.92% | -129.83% | -87.80% |
| Income Before Tax | -318.49% | -128.83% | -281.72% | -127.60% | -87.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -318.49% | -128.83% | -281.72% | -127.60% | -87.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -318.49% | -128.83% | -281.72% | -127.60% | -87.41% |
| EBIT | -59.45% | -46.18% | -280.92% | -129.83% | -87.80% |
| EBITDA | -59.09% | -46.65% | -281.04% | -130.39% | -88.14% |
| EPS Basic | -85.61% | -87.89% | -74.06% | -41.38% | -26.56% |
| Normalized Basic EPS | 37.28% | -87.89% | -200.61% | -41.37% | -26.56% |
| EPS Diluted | -85.61% | -87.89% | -74.06% | -41.38% | -26.56% |
| Normalized Diluted EPS | 37.28% | -87.89% | -200.61% | -41.37% | -26.56% |
| Average Basic Shares Outstanding | 125.50% | 21.77% | 26.99% | 61.03% | 48.10% |
| Average Diluted Shares Outstanding | 125.50% | 21.77% | 26.99% | 61.03% | 48.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |